This review puts forward the importance and flexibility of ATMs in regulating HGP, proposing ATM-based HGP modulation as a potential therapeutic approach for obesity-associated metabolic dysfunction. The gene discussed is SLC25A16; the disease is obesity due to melanocortin 4 receptor deficiency.